5-HT1C receptor activation: a key step in the initiation of migraine?
- 31 August 1989
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (8) , 307-309
- https://doi.org/10.1016/0165-6147(89)90061-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonistsEuropean Journal of Pharmacology, 1989
- Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the anaesthetic siteBritish Journal of Pharmacology, 1989
- Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptorsPsychopharmacology, 1988
- Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptorsBritish Journal of Pharmacology, 1988
- Effect of Meta-Chlorophenylpiperazine (mCPP), A Central Serotonin Agonist and Vascular Serotonin Receptor Antagonist, on Blood Pressure in SHRClinical and Experimental Hypertension. Part A: Theory and Practice, 1987
- Mianserin in the prophylaxis of migraine: a double‐blind studyActa Psychiatrica Scandinavica, 1985
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazineLife Sciences, 1983
- THE EFFECTS OF RESERPINE INJECTION ON METHYSERGIDE TREATED CONTROL AND MIGRAINOUS SUBJECTSHeadache: The Journal of Head and Face Pain, 1974
- Relationships between headache and amine changes after administration of reserpine to migrainous patients.Journal of Neurology, Neurosurgery & Psychiatry, 1969
- Effect of serotonin in migraine patientsNeurology, 1960